Shares of Regeneron Pharmaceuticals, Inc. REGN rose 1.2% after the company reported that US regulators had authorized a lower-dose and subcutaneous version of its COVID-19 antibody treatment.Coherus BioSciences, Inc.’s CHRS shares jumped 1.8% after the company and Junshi Bio jointly disclosed that toripalimab in combination with chemo met primary endpoint as the first-line treatment of metastatic nasopharyngeal carcinoma.Shares of Senseonics Holdings, Inc. SENS surged nearly 42% after the company reported results from a study evaluating its Eversense CGM System for up to 180 days.Cullinan Oncology, Inc.’s CGEM shares jumped 11.3% after the company disclosed Phase 1/2a interim data for its Cullinan Pearl's CLN-081 on 20 patients.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report Coherus BioSciences, Inc. (CHRS): Free Stock Analysis Report Senseonics Holdings, Inc. (SENS): Free Stock Analysis Report Cullinan Oncology Inc. (CGEM): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research